Feasibility study of TAS-118 plus oxaliplatin as perioperative chemotherapy for patients with locally advanced gastric cancer (APOLLO-11).

Daisuke Takahari,Manabu Ohashi,Atsuo Takashima,Takuro Mizukami,Naoki Ishizuka,Hitoshi Katai,Shinya Mikami,Takeru Wakatsuki,Keisho Chin,Satoshi Ida,Koshi Kumagai,Souya Nunobe,Satoru Iwasa,Miki Ito,Takeyuki Wada,Yukinori Yamagata,Takashi Ogura,Takeshi Sano,Narikazu Boku,Kensei Yamaguchi

Feasibility study of TAS-118 plus oxaliplatin as perioperative chemotherapy for patients with locally advanced gastric cancer (APOLLO-11).

2021

205Background:TAS-118 (S-1 and leucovorin) + oxaliplatin (L-OHP) improved overall survival (OS) compared to S-1 + cisplatin for patients (pts) with advanced gastric cancer (GC) (Kang, Lancet Oncol....

Keywords:

perioperative chemotherapy
Oxaliplatin
locally advanced
Internal medicine
Oncology
Medicine
overall survival
Cisplatin
Cancer
advanced gastric cancer

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations